14.3  0.02 (0.14%)		06-23 16:00
Open: 14.95 High: 14.95 Volume: 4,691		Pre. Close: 14.28 Low: 14.3 Market Cap: 27(M)

Short term
Mid term
Targets	6-month :	19.88	1-year :	22.07
Resists	First :	17.02	Second :	18.89
Pivot price	15.72
Supports	First :	14	Second :	11.64
MAs	MA(5) :	15.47	MA(20) :	16.27
	MA(100) :	14.21	MA(250) :	35.68
MACD	MACD :	0	Signal :	0.4
%K %D	K(14,3) :	12.6	D(3) :	23.1
RSI	RSI(14): 42.2
52-week	High :	86	Low :	5.26

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ EUDA ] has closed above bottom band by 3.2%. Bollinger Bands are 68.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	14.96 - 15.05	15.05 - 15.13
Low:	14.09 - 14.2	14.2 - 14.29
Close:	14.14 - 14.29	14.29 - 14.44

EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.

Thu, 18 Jun 2026
EUDA Health Holdings Ltd (EUDA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Thu, 18 Jun 2026
EUDA Health Holdings Ltd (EUDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Wed, 10 Jun 2026
EUDA (EUDA) suspends and terminates $10M at-the-market share offering with Chardan - Stock Titan

Mon, 08 Jun 2026
Tan Meng Dong holds 15.3% of EUDA (NASDAQ: EUDA) in amended Schedule 13G - Stock Titan

Mon, 01 Jun 2026
EUDA Health regains Nasdaq compliance after meeting minimum market value standards - MSN

Mon, 01 Jun 2026
EUDA Health expands product line with new stem cell mask - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	3 (M)
Shares Float	1 (M)
Held by Insiders	49.4 (%)
Held by Institutions	0 (%)
Shares Short	8 (K)
Shares Short P.Month	87 (K)

EPS	-1.49
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-2.25
Profit Margin	-40.7 %
Operating Margin	-34.8 %
Return on Assets (ttm)	-89.4 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	78.9 %
Gross Profit (p.s.)	1
Sales Per Share	2.28
EBITDA (p.s.)	-0.75
Qtrly Earnings Growth	0 %
Operating Cash Flow	-2 (M)
Levered Free Cash Flow	-1 (M)

PE Ratio	-9.67
PEG Ratio	0
Price to Book value	-6.36
Price to Sales	6.26
Price to Cash Flow	-17.6

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.